Luther King Capital Management (LKCM)’s Zimmer Biomet ZBH Stock Holding History

Luther King Capital Management (LKCM)’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,223	Closed	-$201K	–	632
2026 Q1	$201K	Buy	+2,223	New	+$204K	﹤0.01%	586
2025 Q4	–	Sell	-2,223	Closed	-$219K	–	630
2025 Q3	$219K	Sell	2,223 -100	-4%	-$9.91K	﹤0.01%	573
2025 Q2	$212K	Hold	2,323	–	–	﹤0.01%	562
2025 Q1	$263K	Hold	2,323	–	–	﹤0.01%	537
2024 Q4	$245K	Hold	2,323	–	–	﹤0.01%	541
2024 Q3	$251K	Hold	2,323	–	–	﹤0.01%	553
2024 Q2	$252K	Hold	2,323	–	–	﹤0.01%	541
2024 Q1	$307K	Hold	2,323	–	–	﹤0.01%	518
2023 Q4	$283K	Hold	2,323	–	–	﹤0.01%	521
2023 Q3	$261K	Hold	2,323	–	–	﹤0.01%	532
2023 Q2	$338K	Sell	2,323 -600	-21%	-$81.5K	﹤0.01%	519
2023 Q1	$378K	Sell	2,923 -162	-5%	-$20.3K	﹤0.01%	491
2022 Q4	$393K	Hold	3,085	–	–	﹤0.01%	480
2022 Q3	$323K	Hold	3,085	–	–	﹤0.01%	500
2022 Q2	$324K	Buy	3,085 +162	+6%	+$19.2K	﹤0.01%	534
2022 Q1	$374K	Sell	2,923 -110	-4%	-$13.3K	﹤0.01%	515
2021 Q4	$374K	Sell	3,033 -62	-2%	-$8.11K	﹤0.01%	526
2021 Q3	$440K	Hold	3,095	–	–	﹤0.01%	506
2021 Q2	$483K	Hold	3,095	–	–	﹤0.01%	505
2021 Q1	$481K	Hold	3,095	–	–	﹤0.01%	463
2020 Q4	$463K	Sell	3,095 -979	-24%	-$138K	﹤0.01%	455
2020 Q3	$538K	Sell	4,074 -515	-11%	-$67.3K	﹤0.01%	400
2020 Q2	$532K	Buy	4,589 +85	+2%	+$9.79K	﹤0.01%	394
2020 Q1	$442K	Buy	4,504 +566	+14%	+$74.2K	﹤0.01%	395
2019 Q4	$572K	Buy	3,938 +911	+30%	+$126K	﹤0.01%	409
2019 Q3	$403K	Hold	3,027	–	–	﹤0.01%	437
2019 Q2	$346K	Hold	3,027	–	–	﹤0.01%	444
2019 Q1	$375K	Hold	3,027	–	–	﹤0.01%	437
2018 Q4	$305K	Hold	3,027	–	–	﹤0.01%	449
2018 Q3	$386K	Hold	3,027	–	–	﹤0.01%	447
2018 Q2	$328K	Buy	3,027 +360	+13%	+$39.2K	﹤0.01%	456
2018 Q1	$282K	Sell	2,667 -20,739	-89%	-$2.41M	﹤0.01%	468
2017 Q4	$2.74M	Buy	23,406 +20,585	+730%	+$2.33M	0.02%	261
2017 Q3	$321K	Sell	2,821 -1,002	-26%	-$116K	﹤0.01%	438
2017 Q2	$477K	Sell	3,823 -1,545	-29%	-$183K	﹤0.01%	396
2017 Q1	$636K	Hold	5,368	–	–	0.01%	389
2016 Q4	$538K	Hold	5,368	–	–	0.01%	398
2016 Q3	$678K	Hold	5,368	–	–	0.01%	375
2016 Q2	$627K	Hold	5,368	–	–	0.01%	386
2016 Q1	$556K	Sell	5,368 -292	-5%	-$28.2K	0.01%	393
2015 Q4	$564K	Buy	5,660 +177	+3%	+$17.3K	0.01%	401
2015 Q3	$500K	Sell	5,483 -6,677	-55%	-$669K	﹤0.01%	416
2015 Q2	$1.29M	Sell	12,160 -2,173	-15%	-$240K	0.01%	343
2015 Q1	$1.64M	Sell	14,333 -3,476	-20%	-$397K	0.01%	321
2014 Q4	$1.96M	Sell	17,809 -577	-3%	-$60.8K	0.02%	311
2014 Q3	$1.79M	Buy	18,386 +454	+3%	+$44.7K	0.01%	329
2014 Q2	$1.81M	Sell	17,932 -252	-1%	-$24.6K	0.01%	329
2014 Q1	$1.67M	Buy	18,184 +7,410	+69%	+$683K	0.01%	333
2013 Q4	$975K	Sell	10,774 -5,449	-34%	-$472K	0.01%	386
2013 Q3	$1.29M	Sell	16,223 -5,231	-24%	-$412K	0.01%	390
2013 Q2	$1.56M	Buy	+21,454	New	+$1.6M	0.01%	361

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Luther King Capital Management (LKCM)'s ZBH Position: Q2 2026 in Review

Luther King Capital Management (LKCM) sold out of Zimmer Biomet (ZBH) in Q2 2026, closing a stake of 2,223 shares — an estimated $201K sold.

Luther King Capital Management (LKCM) first reported a position in ZBH in Q2 2013 and held it in 51 quarters. The position peaked at $2.74M in Q4 2017. 913 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Luther King Capital Management (LKCM) reported no remaining Zimmer Biomet position as of Q2 2026 after selling out during the quarter.
Luther King Capital Management (LKCM) sold 2,223 Zimmer Biomet shares in Q2 2026, an estimated $201K.
Luther King Capital Management (LKCM) first reported a position in Zimmer Biomet in Q2 2013 and held it in 51 quarters.
Luther King Capital Management (LKCM)'s Zimmer Biomet position peaked at $2.74M in Q4 2017.
913 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q2 2026, filed 10 Aug 2026.